Literature DB >> 16259549

Metabolic side effects of second-generation antipsychotics in children and adolescents: a different story?

Christoph U Correll1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16259549     DOI： 10.4088/jcp.v66n1018

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  8 in total

1.  Metabolic side effects of risperidone in children and adolescents with early-onset schizophrenia.

Authors:  Jean-Louis Goëb; Sophie Marco; Alain Duhamel; Renaud Jardri; Geraldine Kechid; Régis Bordet; Pierre Delion; Pierre Thomas
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

Review 2.  Second generation antipsychotic-induced weight gain in youth with autism spectrum disorders: a brief review of mechanisms, monitoring practices, and indicated treatments.

Authors:  Jeffrey Goltz; Iliyan Ivanov; Timothy R Rice
Journal:  Int J Dev Disabil       Date:  2019-07-14

3.  Increased Risk of Obesity and Metabolic Dysregulation Following 12 Months of Second-Generation Antipsychotic Treatment in Children: A Prospective Cohort Study.

Authors:  Rebecca Ronsley; Duc Nguyen; Jana Davidson; Constadina Panagiotopoulos
Journal:  Can J Psychiatry       Date:  2015-10       Impact factor: 4.356

4.  The role of pharmacotherapy in the management of self-regulation difficulties in young children.

Authors:  Pratibha N Reebye; Dean Elbe
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-05

Review 5.  Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review.

Authors:  José María Martínez-Ortega; Silvia Funes-Godoy; Francisco Díaz-Atienza; Luis Gutiérrez-Rojas; Lucía Pérez-Costillas; Manuel Gurpegui
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-03-17       Impact factor: 4.785

6.  Future Directions Concerning the Impact of Childhood and Adolescent Adversities in the Field of Men's Mental Health: The New York Declaration.

Authors:  Timothy R Rice; Zoltan Rihmer; Julia Golier; Leo Sher
Journal:  Front Public Health       Date:  2015-01-19

7.  Stepped Treatment for Attention-Deficit/Hyperactivity Disorder and Aggressive Behavior: A Randomized, Controlled Trial of Adjunctive Risperidone, Divalproex Sodium, or Placebo After Stimulant Medication Optimization.

Authors:  Joseph C Blader; Steven R Pliszka; Vivian Kafantaris; Carmel A Foley; Gabrielle A Carlson; Judith A Crowell; Brigitte Y Bailey; Colin Sauder; W Burleson Daviss; Christa Sinha; Thomas L Matthews; David M Margulies
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2020-01-30       Impact factor: 8.829

8.  Evidence review and clinical guidance for the use of ziprasidone in Canada.

Authors:  David M Gardner; Andrea L Murphy; Stan Kutcher; Serge Beaulieu; Carlo Carandang; Alain Labelle; Pierre Lalonde; Ashok Malla; Heather Milliken; Claire O'Donovan; Ayal Schaffer; Jorge Soni; Valerie H Taylor; Richard Williams
Journal:  Ann Gen Psychiatry       Date:  2013-01-24       Impact factor: 3.455
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.